Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)
--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a single dose of SCB-219M, with durable responses through at least...
PINTEC ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE FIRST HALF OF 2023
BEIJING, Dec. 29, 2023 /PRNewswire/ -- Pintec Technology Holdings Limited (Nasdaq: PT) ("Pintec" or the "Company"), a Nasdaq-listed company providing technology enabled financial and...
US Powerball Jackpot Soars to Approximately AU$1.1 Billion at Year's End, Australians Can Join the Excitement at theLotter Australia
SYDNEY, Dec. 29, 2023 /PRNewswire/-- The US Powerball lottery, known worldwide for offering the biggest jackpots, is on its way to setting new records. As...
Saving Species Challenge Attracts Global Interest
52 applicants in the running for $1 million INDIANAPOLIS, Dec. 29, 2023 /PRNewswire/ -- The Indianapolis Zoo's bold new conservation initiative will award...
HANSIZHUANG Sets Sail in Indonesia Market
The 1st China anti-PD-1 monoclonal antibody successfully approved in Southeast Asia - The 1st overseas approval of HANSIZHUANG, highlighting another...
Widebrain's Metazium Powers Next Wave of Immersive Digital Collaboration Tools
SEOUL, South Korea, Dec. 28, 2023 /PRNewswire/ -- Widebrain, the leader in enterprise XR content and services, has unveiled its immersive communication platform for business,...
